# The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules

> **NCT05042245** · PHASE4 · COMPLETED · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 237 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Ornithine aspartate granule
- **DRUG:** Silymarin capsule
- **DRUG:** Silymarin capsule simulant
- **DRUG:** Ornithine aspartate granule simulant

## Key facts

- **NCT ID:** NCT05042245
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-23
- **Primary completion:** 2022-12-18
- **Final completion:** 2022-12-20
- **Target enrollment:** 237 (ACTUAL)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05042245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05042245, "The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05042245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*